Intended for healthcare professionals


UK report recommends medical trials of cannabis

BMJ 1998; 317 doi: (Published 14 November 1998) Cite this as: BMJ 1998;317:1337
  1. Hugh Matthews
  1. BMJ

    Britain's House of Lords Science and Technology Committee recommended in a report published this week that cannabis should be reclassified as a schedule 2 drug, allowing research and prescription by doctors on a named patient basis.

    The report called for clinical trials of cannabis in the treatment of multiple sclerosis and chronic pain but recommended that doctors should …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription